Evidence map›Paper›PMID 32200728›Full record

ArticleJournal of the American Heart Association2020

Preprocedural Troponin T Levels Predict the Improvement in the Left Ventricular Ejection Fraction After Catheter Ablation of Atrial Fibrillation/Flutter.

Daisetsu Aoyama, Shinsuke Miyazaki, Kanae Hasegawa, Kenichi Kaseno, Eri Ishikawa, Moe Mukai, Minoru Nodera, Kosuke Miyahara, Akira Matsui, Yuichiro Shiomi and 7 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 1 institution in 1 country.

Daisetsu AoyamaDepartment of Cardiovascular Medicine Faculty of Medical Sciences University of Fukui Japan.
Shinsuke MiyazakiDepartment of Cardiovascular Medicine Faculty of Medical Sciences University of Fukui Japan.
Kanae HasegawaDepartment of Cardiovascular Medicine Faculty of Medical Sciences University of Fukui Japan.
Kenichi KasenoDepartment of Cardiovascular Medicine Faculty of Medical Sciences University of Fukui Japan.
Eri IshikawaDepartment of Cardiovascular Medicine Faculty of Medical Sciences University of Fukui Japan.
Moe MukaiDepartment of Cardiovascular Medicine Faculty of Medical Sciences University of Fukui Japan.
Minoru NoderaDepartment of Cardiovascular Medicine Faculty of Medical Sciences University of Fukui Japan.
Kosuke MiyaharaDepartment of Cardiovascular Medicine Faculty of Medical Sciences University of Fukui Japan.
Akira MatsuiDepartment of Cardiovascular Medicine Faculty of Medical Sciences University of Fukui Japan.
Yuichiro ShiomiDepartment of Cardiovascular Medicine Faculty of Medical Sciences University of Fukui Japan.
Naoto TamaDepartment of Cardiovascular Medicine Faculty of Medical Sciences University of Fukui Japan.
Hiroyuki IkedaDepartment of Cardiovascular Medicine Faculty of Medical Sciences University of Fukui Japan.
Yoshitomo FukuokaDepartment of Cardiovascular Medicine Faculty of Medical Sciences University of Fukui Japan.
Tetsuji MorishitaDepartment of Cardiovascular Medicine Faculty of Medical Sciences University of Fukui Japan.
Kentaro IshidaDepartment of Cardiovascular Medicine Faculty of Medical Sciences University of Fukui Japan.
Hiroyasu UzuiDepartment of Cardiovascular Medicine Faculty of Medical Sciences University of Fukui Japan.
Hiroshi TadaDepartment of Cardiovascular Medicine Faculty of Medical Sciences University of Fukui Japan.
University of Fukui · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Left ventricular (LV) systolic dysfunction is reversible in some patients once the arrhythmia is controlled. However, identifying this arrhythmia-induced cardiomyopathy among patients with LV systolic dysfunction is challenging. We explored the factors predicting the reversibility of the LV ejection fraction (LVEF) after catheter ablation of atrial fibrillation and/or atrial flutter in patients with LV systolic dysfunction. Methods and Results Forty patients with a reduced LVEF (LVEF <50%; 66.2±10.7 years; 32 men) who underwent atrial fibrillation/atrial flutter ablation were included. Transthoracic echocardiography was performed before and during the early (<4 days) and late phases (>3 months) after the ablation. Responders were defined as having a normalized LVEF (≥50%) during the late phase after the ablation. The LVEF improved from 39.8±8.8 to 50.9±10.9% at 1.2±0.6 days after the procedure, and to 56.2±12.2% at 9.6±8.0 months after the procedure (both for

Indexed as

Catheter AblationStroke VolumeVentricular Function, LeftAgedAtrial FibrillationAtrial FlutterBiomarkersFemaleHumansMaleMiddle AgedRecovery of FunctionRetrospective StudiesRisk AssessmentRisk FactorsSystoleBiomarkersTroponin Tarrhythmia‐induced cardiomyopathyatrial fibrillationcatheter ablationleft ventricular dysfunctiontroponin T

Identifiers

PMID32200728
PMCPMC7428643
OpenAlexW3012622750

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.